Showing posts with the label Myriad Genetics

Burning Rock Announces In-Licensing of Myriad myChoice® Tumor Testing in China

Burning Rock Biotech announced that it entered into a development and commercialization agreement with Myriad Genetics which will bring myChoice® tumor testing for homologous recombination deficiency…

German Federal Joint Committee (G-BA) Issues Nationwide Reimbursement Decision for EndoPredict® Breast Cancer Prognostic Test

Myriad Genetics announced today that the German Federal Joint Committee (G-BA) has successfully completed the method evaluation assessment for the EndoPredict® breast cancer prognostic test. The posi…
Subscribe Our Newsletter